Feb 142025
 

New Shortages February 14, 2025 Erythromycin Topical Gel (Discontinuation) Shortage Updates February 14, 2025 Amoxicillin Powder, For Suspension (Currently In Shortage) Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine

Feb 132025
 

Shortage Updates February 13, 2025 Fentanyl Citrate Injection (Currently In Shortage) Furosemide Injection (Currently In Shortage) Hydromorphone Hydrochloride Injection (Currently In Shortage) Morphine Sulfate Injection (Currently In Shortage)

Feb 122025
 

New Shortages February 12, 2025 Amantadine Hydrochloride Capsule (Discontinuation) Shortage Updates February 12, 2025 Azacitidine Injection (Currently In Shortage) Bupivacaine Hydrochloride Injection (Currently In Shortage) Dexamethasone Sodium Phosphate

Feb 072025
 

New Shortages February 7, 2025 Benazepril Hydrochloride Tablet (Discontinuation) Shortage Updates February 7, 2025 Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (Currently In Shortage) Dexamethasone Sodium Phosphate Injection (Currently In

Feb 062025
 

New Shortages February 6, 2025 Glipizide Tablet, Extended Release (Discontinuation) Idarubicin Hydrochloride Injection (Discontinuation) Varenicline Tartrate Tablet (Discontinuation) Shortage Updates February 6, 2025 Dextrose Monohydrate 50% Injection (Currently In

Feb 012025
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Journavx suzetrigine 1/30/2025 To treat moderate to severe acute

Jan 312025
 

Date Brand Name(s) Description Type Reason Company  1/31/2025 Alvogen Fentanyl Transdermal System 25 mcg/h transdermal patches Drugs There is potential that patches could be multi-stacked,